Brian Herndier is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of medical research, particularly in the area of cancer diagnosis and treatment. With a total of 6 patents to his name, Herndier's work has the potential to impact the lives of many patients.

Latest Patents

Herndier's latest patents include groundbreaking inventions such as the "Retrovirus isolated from mantle histiocytes in mantle cell lymphoma." This invention features an isolated, intact virus associated with human lymphoma, originally isolated from a mantle cell lymphoma, referred to as a mantle histiocyte retrovirus (MHRV). The patent also includes compositions and methods for detecting MHRV, as well as methods for propagating MHRV in vitro, screening for anti-MHRV agents, and generating attenuated MHRV strains. Another significant patent is focused on the "Diagnosis and treatment of cancer having clonal macrophage involvement." This invention addresses the presence of clonal macrophages in pre-cancerous and cancerous tissue, providing methods and kits for diagnosis and treatment of cancers induced by clonal macrophage expansion.

Career Highlights

Brian Herndier is affiliated with the University of California, where he continues to advance his research and innovations. His work is characterized by a commitment to improving cancer diagnosis and treatment methodologies.

Collaborations

Some of his notable coworkers include Michael S McGrath and Bruce Shiramizu, who have collaborated with him on various research projects.

Conclusion

Brian Herndier's contributions to medical research and his innovative patents demonstrate his dedication to advancing cancer treatment and diagnosis. His work continues to inspire and pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com